Serum urate normalisation ‐ not reported · people with chronic gout
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events participant and study investigator reported · people with chronic gout
Skim milk enriched with GMP/G600 showed no clear difference in serious adverse events participant and study investigator reported compared with skim milk & lactose powder (low certainty).
1 finding from 1 review
Intervention not reported
Pain reduction 10 cm VAS. Scale from: 0 to 10 cm (0 is no pain). · patients with acute gout
1 finding from 1 review
Intervention not reported
Number of participant withdrawals due to adverse events ‐ not measured · patients with acute gout
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
Reduction of joint inflammation Tape measure ‐ joint circumference (cm) · patients with acute gout
1 finding from 1 review
Intervention not reported
Joint function ‐ not measured · patients with acute gout
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
Health‐related quality of life ‐ not measured · patients with acute gout
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
Patient global assessment ‐ not measured · patients with acute gout
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
Serious adverse events ‐ not measured · patients with acute gout
The review found no eligible studies for this question.
1 finding from 1 review
Pain VAS 0‐100 (higher means worse) · patients with hand osteoarthritis
1 finding from 1 review
Intervention not reported
Adverse events Event episodes (n) reported · patients with osteoarthritis of the knee
The intervention probably leads to higher adverse events Event episodes (n) reported (moderate certainty).
1 finding from 1 review
Intervention not reported
Adverse events Participants (n) withdrew due to adverse effects · patients with osteoarthritis of the knee
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Adverse events Participants (n) reported serious adverse events · patients with osteoarthritis of the knee
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Quality of Life · patients with osteoarthritis of the knee
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Pain VAS 0‐100 (higher means worse) · patients with osteoarthritis of the knee
1 finding from 1 review
Intervention not reported
Function: change from baseline WOMAC VAS (Function; higher means worse) · patients with osteoarthritis of the knee
1 finding from 1 review
Intervention not reported
Adverse events Participants (n) reported adverse events · patients with osteoarthritis of the knee
The intervention showed no clear difference in adverse events Participants (n) reported adverse events (moderate certainty).
1 finding from 1 review
Intervention not reported
Adverse events Participants (n) withdrew due to adverse effects · patients with osteoarthritis of the knee
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Adverse events Participants (n) reported serious adverse events · patients with osteoarthritis of the knee
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Quality of life SF‐36 4 · patients with osteoarthritis of the knee
1 finding from 1 review